Investor overview
The pharmacy network for compounded medicine
Pharmacies on AffinityRx
What we build
Two marketplaces on one network of vetted pharmacies.
A B2B marketplace where clinics source GLP-1s, hormones, and other compounded medications from pharmacies.
A B2B marketplace where pharmacies source wholesale supplies, APIs, PPE, medical device, plastics, garbing, etc from suppliers.
Where we are
Business model
We buy at negotiated bulk prices and earn the spread. Clinics pay $0 to join.
Example clinic
Industry averages
Market size
Why AffinityRx wins
Volume from thousands of clinics lets us negotiate prices no single clinic can, without trading away quality.
Every order makes routing smarter about stock, speed, and price across pharmacies.
Clinic and patient ratings verify quality in a way no single pharmacy can.
Next, pharmacies buy APIs, supplies, and equipment from vetted suppliers in the same network.
Team
Frequently asked questions
AffinityRx negotiates bulk prices with pharmacies and earns the spread on medication volume. Clinics pay $0 to join, with no subscription or per-order fees.
No. Licensed compounding pharmacies dispense every order. AffinityRx is the marketplace and routing layer between them and clinics.
Controlled-substance support arrives in Q2 2027 and office-use ordering with 503B outsourcing facilities in Q4 2026–Q1 2027. A pharmacy-to-supplier marketplace follows.
See the roadmap